Organigram Holdings Inc.

Equities

OGI

CA68620P7056

Healthcare Facilities & Services

Market Closed - Toronto S.E. Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
2.71 ^CAD	-1.81%		+12.92%	+57.56%

May. 14	Toronto Stocks Edge Down; Hudbay Minerals Rises on 1Q Earnings Beat	DJ
May. 14	Transcript : Organigram Holdings Inc., Q2 2024 Earnings Call, May 14, 2024

Organigram Holdings Inc. Reports Earnings Results for the Thirteen Months Ended September 30, 2023

December 19, 2023 at 07:10 am EST

Organigram Holdings Inc. reported earnings results for the thirteen months ended September 30, 2023. For the thirteen months, the company reported sales was CAD 233.65 million. Revenue was CAD 161.64 million.

Net loss was CAD 248.6 million. Basic loss per share from continuing operations was CAD 3.058. Diluted loss per share from continuing operations was CAD 3.058.

Latest news about Organigram Holdings Inc.

Toronto Stocks Edge Down; Hudbay Minerals Rises on 1Q Earnings Beat	May. 14	DJ
Transcript : Organigram Holdings Inc., Q2 2024 Earnings Call, May 14, 2024	May. 14
Organigram Fiscal Q2 Loss Surges as Revenue Falls 5%	May. 14	MT
Organigram Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	May. 14	CI
Organigram Brief: Q2 Fiscal 2024 Net loss was $27.1 million compared to $7.5 million in Q2 Fiscal 2023	May. 14	MT
Organigram Brief: Q2 Fiscal 2024 overall net revenue decreased 5% to $37.6 million, from $39.5 million in Q2 Fiscal 2023	May. 14	MT
Organigram Brief: Q2 Fiscal 2024 recreational net revenue increased 21% to $33.1 million from $27.4 million in the second quarter ended February 28, 2023	May. 14	MT
North American Morning Briefing : Powell Comments, -2-	Apr. 16	DJ
Alliance Global Upgrades OrganiGram Holdings to Buy From Neutral	Apr. 15	MT
Organigram Holdings Completes Underwritten Public Offering	Apr. 02	MT
Cannabis Stocks: Wedbush Notes Florida Supreme Court Approved Proposed Amendment For Adult Use Cannabis to be Placed on the 2024 General Election Ballot	Apr. 02	MT
Organigram Reports Overnight Marketed Public Offering; Down Over 19%	Mar. 27	MT
Organigram Reports Overnight Marketed Public Offering	Mar. 27	MT
Organigram Reports Minority Investment in Open Book Extracts; Up 8.8%	Mar. 26	MT
Organigram Up 2.2% In US Premarket After Receiving Health Canada's Final Redetermination on Jolts	Mar. 25	MT
Organigram Holdings Inc. Receives Health Canada?S Final Redetermination on Jolts	Mar. 22	CI
Organigram Notes The Standing Committee on Finance's Recommendation on Excise Duty	Feb. 28	MT
Organigram Swings to Loss in Fiscal Q1, Net Revenue Falls; Provides Outlook; Down Over 13%	Feb. 13	MT
Transcript : Organigram Holdings Inc., Q1 2024 Earnings Call, Feb 13, 2024	Feb. 13
Organigram Swings to Loss in Fiscal Q1, Net Revenue Falls; Provides Outlook	Feb. 13	MT
Organigram Holdings Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 13	CI
North American Morning Briefing : Stocks Seen -2-	Feb. 13	DJ
Organigram Brief: Compared to the prior period, net revenue decreased 16% to US$36.5 million, from $43.3 million in Q1 Fiscal 2023	Feb. 13	MT
Organigram Brief: Achieved positive Adjusted EBITDA and positive cash flow from operations of US$7.7 million	Feb. 13	MT
Organigram Holdings Reports First Shipment to Germany	Jan. 31	MT

Chart Organigram Holdings Inc.

Duration

Period

More charts

Company Profile

Organigram Holdings Inc. operates through its subsidiaries. The Companyâs major wholly owned subsidiaries include Organigram Inc., 10870277 Canada Inc., The Edibles and Infusions Corporation (EIC), and Laurentian Organic Inc. (Laurentian). Organigram Inc. is a licensed producer (LP) of cannabis, cannabis-derived products and cannabis infused edibles in Canada. It is focused on producing cannabis for patients and adult recreational consumers, as well as developing international business partnerships. It has also developed and owns a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag Oâ Buds, SHRED, SHREDâems, Monjour, Laurentian, Tremblant Cannabis and Trailblazer. It operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. 10870277 Canada Inc. is a special purpose holding company for the Company. EIC is a cannabis processor of confectionary goods.

Sector

Healthcare Facilities & Services

Calendar

2024-07-10 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Organigram Holdings Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.71 CAD

Average target price

3.629 CAD

Spread / Average Target

+33.90%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Farming

	1st Jan change	Capi.
ORGANIGRAM HOLDINGS INC.	+57.56%	206M
THE CANNABIST COMPANY HOLDINGS INC.	-37.75%	341M
CRUCIAL INNOVATIONS CORP.	-.--%	339M
AYR WELLNESS INC.	+52.26%	299M
ASCEND WELLNESS HOLDINGS, INC.	+35.05%	279M
JUSHI HOLDINGS INC.	+52.17%	138M
INTERCURE LTD.	+140.77%	137M
IANTHUS CAPITAL HOLDINGS, INC.	-28.57%	122M
4FRONT VENTURES CORP.	+34.62%	118M
BAKHU HOLDINGS, CORP.	+100.00%	60.26M

Medical Farming